Author
Listed:
- Chi-Lam Au-Yeung
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at Houston)
- Tsz-Lun Yeung
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at Houston)
- Abhinav Achreja
(University of Michigan)
- Hongyun Zhao
(University of Michigan)
- Kay-Pong Yip
(University of South Florida)
- Suet-Ying Kwan
(The University of Texas MD Anderson Cancer Center)
- Michaela Onstad
(The University of Texas MD Anderson Cancer Center)
- Jianting Sheng
(Houston Methodist Research Institute, Weill Cornell Medicine
Center for Precision Oncology, Houston Methodist Cancer Center)
- Ying Zhu
(Houston Methodist Research Institute, Weill Cornell Medicine
Center for Precision Oncology, Houston Methodist Cancer Center)
- Dodge L. Baluya
(The University of Texas MD Anderson Cancer Center)
- Ngai-Na Co
(The University of Texas MD Anderson Cancer Center)
- Angela Rynne-Vidal
(The University of Texas MD Anderson Cancer Center)
- Rosemarie Schmandt
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at Houston)
- Matthew L. Anderson
(Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine)
- Karen H. Lu
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at Houston)
- Stephen T. C. Wong
(Houston Methodist Research Institute, Weill Cornell Medicine
Center for Precision Oncology, Houston Methodist Cancer Center)
- Deepak Nagrath
(University of Michigan)
- Samuel C. Mok
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at Houston)
Abstract
Advanced ovarian cancer usually spreads to the omentum. However, the omental cell-derived molecular determinants modulating its progression have not been thoroughly characterized. Here, we show that circulating ITLN1 has prognostic significance in patients with advanced ovarian cancer. Further studies demonstrate that ITLN1 suppresses lactotransferrin’s effect on ovarian cancer cell invasion potential and proliferation by decreasing MMP1 expression and inducing a metabolic shift in metastatic ovarian cancer cells. Additionally, ovarian cancer-bearing mice treated with ITLN1 demonstrate marked decrease in tumor growth rates. These data suggest that downregulation of mesothelial cell-derived ITLN1 in the omental tumor microenvironment facilitates ovarian cancer progression.
Suggested Citation
Chi-Lam Au-Yeung & Tsz-Lun Yeung & Abhinav Achreja & Hongyun Zhao & Kay-Pong Yip & Suet-Ying Kwan & Michaela Onstad & Jianting Sheng & Ying Zhu & Dodge L. Baluya & Ngai-Na Co & Angela Rynne-Vidal & Ro, 2020.
"ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment,"
Nature Communications, Nature, vol. 11(1), pages 1-16, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-17383-2
DOI: 10.1038/s41467-020-17383-2
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-17383-2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.